3M’s October Sales Update Reflects Deceleration; Street Stays Cautious
Former WeWork China exec launches a ‘startup studio’ for real estate
Bonhoeffer Fund 3Q20 Commentary – Case Study: MMA Capital (MMAC)
COVID-19 vaccine update: Pfizer may be the frontrunner, but Canada has hedged its bets
This Week in Apps: Conservative apps surge, Instagram redesigned, TikTok gets ghosted
Week Ahead – Focus stays on COVID
Buying a coronavirus vaccine for everyone on Earth, storing and shipping it, and giving it safely will all be hard and expensive
Chart of the WeekData Disruption: The Impact of COVID-19 on Inflation Measurement
Novavax on track to begin U.S. trial of Covid-19 vaccine in November
Weekly data preview: claimant count change and the RBNZ
US COVID-19 Deaths Top 1,000 For 4th Time This Week As World Awaits Biden Plan: Live Updates
US COVID-19 Cases Top 100k For Record 3rd Straight Day As Hospitalizations Near New Highs: Live Updates
US COVID-19 Hospitalizations May Be Headed For All-Time Highs: Live Updates
Global COVID-19 Cases Near 50 Million As Deaths Slow After Record Jump: Live Updates
COVID-19 drug and vaccine patents are putting profit before people
Figure of the week: The post-pandemic road to economic recovery in Africa
Estée Lauder Beats Q1 Forecasts On Strength in Skincare, Asia Pacific
Ring 20: Could the rare disease get left behind by next-generation gene sequencing?
"The Worst Isn't Behind Us" - These Are The World's Most At-Risk-Of-Insolvency Airlines
John Snow Memo v. Great Barrington – The Johns Hopkins Debate
What digital revolution? Hundreds of millions of farmers still cannot get online
J&J Strikes Covid-19 Vaccine Manufacturing Deal With Aspen
November Monthly
AstraZeneca Sells Rights To Hypertension Drugs For $400M
More testing shows more iceberg
Is China An Existential Threat To America?
Central Banks Sell Gold For The First Time In 10 Years Due To Just Two Countries
Week Ahead – Election Time!
Indian pharma is being squeezed – and it's bad news for drug access in developing countries
Astrazeneca Scores $286.9M US Army Contract For Covid Vaccine